Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development Program
Crossref DOI link: https://doi.org/10.1007/s11892-016-0728-4
Published Online: 2016-04-01
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Peng, Hui
Want, Laura L.
Aroda, Vanita R.
Text and Data Mining valid from 2016-04-01